As part of Open Journals’ initiatives, we create website for scholarly open access journals.
If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at
https://ejournalplus.com or send us an email to info@ejournalplus.com
Pathogenic microbiological flora in middle ear mucosa of chronic otitis media inactive mucosal disease: Relevance in surgical outcome of tympanoplasty: A pilot study
Background & Aim: Chronic Otitis Media (COM) is a common curable cause for hearing impairment in developing countries. Eradication of disease from middle ear and repair of tympanic membrane perforation reduces the progression of hearing loss due to infection induced osteitis of ossicles. Tympanoplasty is usually done in quiescent stage of COM. Eustachian tube function, allergies and duration of disease affect the outcome of surgery. Our study aimed to assess middle ear mucosa for microbiological flora in COM Mucosal disease Inactive stage and its influence on outcome.
(2022). Pathogenic microbiological flora in middle ear mucosa of chronic otitis media inactive mucosal disease: Relevance in surgical outcome of tympanoplasty: A pilot study. European Journal of Molecular & Clinical Medicine, 9(6), 1898-1906.
Divya Mohan; Rajarajeswari Nalamate; Tambi A Cherian; Meenu Khurana Cherian; Shashikala Nair. "Pathogenic microbiological flora in middle ear mucosa of chronic otitis media inactive mucosal disease: Relevance in surgical outcome of tympanoplasty: A pilot study". European Journal of Molecular & Clinical Medicine, 9, 6, 2022, 1898-1906.
(2022). 'Pathogenic microbiological flora in middle ear mucosa of chronic otitis media inactive mucosal disease: Relevance in surgical outcome of tympanoplasty: A pilot study', European Journal of Molecular & Clinical Medicine, 9(6), pp. 1898-1906.
Pathogenic microbiological flora in middle ear mucosa of chronic otitis media inactive mucosal disease: Relevance in surgical outcome of tympanoplasty: A pilot study. European Journal of Molecular & Clinical Medicine, 2022; 9(6): 1898-1906.
